Charity Atkins
- Cell Biology top 5%
- Endoplasmic Reticulum Stress and Disease 2
- Epidemiology top 10%
- Autophagy in Disease and Therapy 2
-
- Metabolism, Diabetes, and Cancer 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Kinase Regulation and GTPase Signaling 1
-
- Growth Hormone and Insulin-like Growth Factors 4
-
- Neuroblastoma Research and Treatments 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
- Co-authors
- Rakesh KumarJeffrey M. AxtenAaron S. GoetzElisabeth A. MinthornThomas B. StanleyAnthony E. ChoudhryDavid J. FigueroaHasan Alsaid
- Journals
- Cancer Research (2 papers)Clinical Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Charity Atkins
9 papers receiving 732 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cell Biology 413
- Epidemiology 258
- Molecular Biology 387
- Geriatrics and Gerontology 17
- Physiology 18
Countries citing papers authored by Charity Atkins
This map shows the geographic impact of Charity Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charity Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charity Atkins more than expected).
Fields of papers citing papers by Charity Atkins
This network shows the impact of papers produced by Charity Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charity Atkins. The network helps show where Charity Atkins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charity Atkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 2 | |
| 2 | Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activitybreakdown → | 2013 | 364 |
| 3 | 2013 | 170 | |
| 4 | 2009 | 86 | |
| 5 | 2009 | 62 | |
| 6 | Abstract #1740: Characterization of GSK1838705A, a small molecule inhibitor of the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase that delays growth of IGF-1R-dependent tumors and causes regression of ALK-dependent tumors in vivo | 2009 | 2 |
| 7 | 2008 | 27 | |
| 8 | 2006 | 29 | |
| 9 | 2003 | 7 |
About Charity Atkins
Charity Atkins is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology and Cell Biology, having authored 9 papers that have together received 749 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Autophagy in Disease and Therapy (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Neuroblastoma Research and Treatments (2 papers), Metabolism, Diabetes, and Cancer (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper) and Protein Kinase Regulation and GTPase Signaling (1 paper). The work is most often cited by research in Cell Biology (413 citations), Epidemiology (258 citations) and Molecular Biology (387 citations). Charity Atkins has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Rakesh Kumar, Jeffrey M. Axten, Aaron S. Goetz, Elisabeth A. Minthorn, Thomas B. Stanley, Anthony E. Choudhry, David J. Figueroa, Hasan Alsaid, ShuYun Zhang and Brent Sanders. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.